MHC I PTM and spliced peptide immunopeptidome
downstream-application
MHC I PTM and spliced peptide immunopeptidome: downstream-application. MHC class I immunopeptidomics of Loucy and A375 cells where PEAKS de novo sequencing identified spliced peptides making up about 5 to 7% of the MHC-bound repertoire…
MHC class I immunopeptidomics of Loucy and A375 cells where PEAKS de novo sequencing identified spliced peptides making up about 5 to 7% of the MHC-bound repertoire, validated with synthetic peptides.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Application area | Immunopeptidomics / neoantigen |
Paper describing it
- Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I (2021, Journal of Proteins and Proteomics, peer-reviewed)